메뉴 건너뛰기




Volumn 5, Issue 1, 2008, Pages

Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; CERAMIDE; EPICERAM; FILAGGRIN; FLUTICASONE PROPIONATE; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT; SERINE PROTEINASE INHIBITOR; STEROID; TRICERAM; UNCLASSIFIED DRUG;

EID: 67349164733     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.05.006     Document Type: Review
Times cited : (15)

References (44)
  • 1
    • 84882327155 scopus 로고    scopus 로고
    • New insights into atopic dermatitis
    • Leung D.Y., et al. New insights into atopic dermatitis. J. Clin. Invest. 113 (2004) 651-657
    • (2004) J. Clin. Invest. , vol.113 , pp. 651-657
    • Leung, D.Y.1
  • 2
    • 0034069636 scopus 로고    scopus 로고
    • Atopic dermatitis: new insights and opportunities for therapeutic intervention
    • Leung D.Y. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 105 (2000) 860-876
    • (2000) J. Allergy Clin. Immunol. , vol.105 , pp. 860-876
    • Leung, D.Y.1
  • 3
    • 44649119864 scopus 로고    scopus 로고
    • Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms
    • Elias P.M., Hatano Y., and Williams M.L. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 121 6 (2008) 1337-1343
    • (2008) J Allergy Clin Immunol , vol.121 , Issue.6 , pp. 1337-1343
    • Elias, P.M.1    Hatano, Y.2    Williams, M.L.3
  • 4
    • 42149101196 scopus 로고    scopus 로고
    • Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis
    • Elias P.M., and Steinhoff M. Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J. Invest. Dermatol. 128 (2008) 1067-1070
    • (2008) J. Invest. Dermatol. , vol.128 , pp. 1067-1070
    • Elias, P.M.1    Steinhoff, M.2
  • 5
    • 24344448276 scopus 로고    scopus 로고
    • Stratum corneum defensive functions: an integrated view
    • Elias P.M. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 125 (2005) 183-200
    • (2005) J. Invest. Dermatol. , vol.125 , pp. 183-200
    • Elias, P.M.1
  • 6
    • 26444486975 scopus 로고    scopus 로고
    • Interactions among stratum corneum defensive functions
    • Elias P.M., and Choi E.H. Interactions among stratum corneum defensive functions. Exp. Dermatol. 14 (2005) 719-726
    • (2005) Exp. Dermatol. , vol.14 , pp. 719-726
    • Elias, P.M.1    Choi, E.H.2
  • 7
    • 34748850100 scopus 로고    scopus 로고
    • The skin barrier as an innate immune element
    • Elias P.M. The skin barrier as an innate immune element. Semin. Immunopathol. 29 (2007) 3-14
    • (2007) Semin. Immunopathol. , vol.29 , pp. 3-14
    • Elias, P.M.1
  • 8
    • 0026265525 scopus 로고
    • Structural and lipid biochemical correlates of the epidermal permeability barrier
    • Elias P.M., and Menon G.K. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv. Lipid Res. 24 (1991) 1-26
    • (1991) Adv. Lipid Res. , vol.24 , pp. 1-26
    • Elias, P.M.1    Menon, G.K.2
  • 9
    • 36048989909 scopus 로고    scopus 로고
    • Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice
    • Aberg K.M., et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J. Clin. Invest. 117 (2007) 3339-3349
    • (2007) J. Clin. Invest. , vol.117 , pp. 3339-3349
    • Aberg, K.M.1
  • 10
    • 37049029404 scopus 로고    scopus 로고
    • Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases
    • Stefansson K., et al. Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J. Invest. Dermatol. 128 (2008) 18-25
    • (2008) J. Invest. Dermatol. , vol.128 , pp. 18-25
    • Stefansson, K.1
  • 11
    • 11944270052 scopus 로고    scopus 로고
    • A proteolytic cascade of kallikreins in the stratum corneum
    • Brattsand M., et al. A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124 (2005) 198-203
    • (2005) J. Invest. Dermatol. , vol.124 , pp. 198-203
    • Brattsand, M.1
  • 12
    • 33645401909 scopus 로고    scopus 로고
    • Skin barrier function and allergic risk
    • Hudson T.J. Skin barrier function and allergic risk. Nat. Genet. 38 (2006) 399-400
    • (2006) Nat. Genet. , vol.38 , pp. 399-400
    • Hudson, T.J.1
  • 13
    • 33745524911 scopus 로고    scopus 로고
    • Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis
    • Irvine A.D., and McLean W.H. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J. Invest. Dermatol. 126 (2006) 1200-1202
    • (2006) J. Invest. Dermatol. , vol.126 , pp. 1200-1202
    • Irvine, A.D.1    McLean, W.H.2
  • 14
    • 33645399288 scopus 로고    scopus 로고
    • Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
    • Palmer C.N., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38 (2006) 441-446
    • (2006) Nat. Genet. , vol.38 , pp. 441-446
    • Palmer, C.N.1
  • 15
    • 33644622891 scopus 로고    scopus 로고
    • Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
    • Smith F.J., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat. Genet. 38 (2006) 337-342
    • (2006) Nat. Genet. , vol.38 , pp. 337-342
    • Smith, F.J.1
  • 16
    • 33745353511 scopus 로고    scopus 로고
    • Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations
    • Weidinger S., et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J. Allergy Clin. Immunol. 118 (2006) 214-219
    • (2006) J. Allergy Clin. Immunol. , vol.118 , pp. 214-219
    • Weidinger, S.1
  • 17
    • 33746927999 scopus 로고    scopus 로고
    • Skin barrier function, epidermal proliferation and differentiation in eczema
    • Proksch E., et al. Skin barrier function, epidermal proliferation and differentiation in eczema. J. Dermatol. Sci. 43 (2006) 159-169
    • (2006) J. Dermatol. Sci. , vol.43 , pp. 159-169
    • Proksch, E.1
  • 18
    • 33645129371 scopus 로고    scopus 로고
    • The role of microorganisms in atopic dermatitis
    • Baker B.S. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol. 144 (2006) 1-9
    • (2006) Clin. Exp. Immunol. , vol.144 , pp. 1-9
    • Baker, B.S.1
  • 20
    • 0032887080 scopus 로고    scopus 로고
    • Hypothesis: from epidermal barrier dysfunction to atopic disorders
    • Taieb A. Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 41 (1999) 177-180
    • (1999) Contact Dermatitis , vol.41 , pp. 177-180
    • Taieb, A.1
  • 21
    • 0034871785 scopus 로고    scopus 로고
    • Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications
    • Elias P.M., and Feingold K.R. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch. Dermatol. 137 (2001) 1079-1081
    • (2001) Arch. Dermatol. , vol.137 , pp. 1079-1081
    • Elias, P.M.1    Feingold, K.R.2
  • 22
    • 0036696327 scopus 로고    scopus 로고
    • Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity
    • Chamlin S.L., et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J. Am. Acad. Dermatol. 47 (2002) 198-208
    • (2002) J. Am. Acad. Dermatol. , vol.47 , pp. 198-208
    • Chamlin, S.L.1
  • 23
    • 67349200387 scopus 로고    scopus 로고
    • Sugarman, J. and Parish, L.J. (2008) A topical lipid-based barrier repair formulation (EpiCeram™ cream) is high-effective monotherapy for moderate-to-severe pediatric atopic dermatitis. J. Invest. Dermatol. (Kyoto, Japan), 14-17.
    • Sugarman, J. and Parish, L.J. (2008) A topical lipid-based barrier repair formulation (EpiCeram™ cream) is high-effective monotherapy for moderate-to-severe pediatric atopic dermatitis. J. Invest. Dermatol. (Kyoto, Japan), 14-17.
  • 24
    • 0033832585 scopus 로고    scopus 로고
    • Evidence for the existence of a self-regulated enzymatic process within the human stratum corneum-an unexpected role for urocanic acid
    • Krien P.M., and Kermici M. Evidence for the existence of a self-regulated enzymatic process within the human stratum corneum-an unexpected role for urocanic acid. J. Invest. Dermatol. 115 (2000) 414-420
    • (2000) J. Invest. Dermatol. , vol.115 , pp. 414-420
    • Krien, P.M.1    Kermici, M.2
  • 25
    • 13444249470 scopus 로고    scopus 로고
    • Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response
    • Steinhoff M., et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev. 26 (2005) 1-43
    • (2005) Endocr. Rev. , vol.26 , pp. 1-43
    • Steinhoff, M.1
  • 26
    • 4344587008 scopus 로고    scopus 로고
    • Increased stratum corneum pH promotes activation and release of primary cytokines from the stratum corneum attributable to activation of serine proteases
    • Hachem J.P., et al. Increased stratum corneum pH promotes activation and release of primary cytokines from the stratum corneum attributable to activation of serine proteases. J. Invest. Dermatol. 119 (2002) 258
    • (2002) J. Invest. Dermatol. , vol.119 , pp. 258
    • Hachem, J.P.1
  • 27
    • 0030586613 scopus 로고    scopus 로고
    • IL-1 beta activation in human epidermis
    • Nylander-Lundqvist E., et al. IL-1 beta activation in human epidermis. J. Immunol. 157 (1996) 1699-1704
    • (1996) J. Immunol. , vol.157 , pp. 1699-1704
    • Nylander-Lundqvist, E.1
  • 28
    • 34247578168 scopus 로고    scopus 로고
    • Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema
    • Sandilands A., et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat. Genet. 39 (2007) 650-654
    • (2007) Nat. Genet. , vol.39 , pp. 650-654
    • Sandilands, A.1
  • 29
    • 33745427100 scopus 로고    scopus 로고
    • New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions
    • (quiz 22-23)
    • Cork M.J., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J. Allergy Clin. Immunol. 118 (2006) 3-21 (quiz 22-23)
    • (2006) J. Allergy Clin. Immunol. , vol.118 , pp. 3-21
    • Cork, M.J.1
  • 30
    • 0035722018 scopus 로고    scopus 로고
    • Stress-induced changes in skin barrier function in healthy women
    • Altemus M., et al. Stress-induced changes in skin barrier function in healthy women. J. Invest. Dermatol. 117 (2001) 309-317
    • (2001) J. Invest. Dermatol. , vol.117 , pp. 309-317
    • Altemus, M.1
  • 31
    • 0035144999 scopus 로고    scopus 로고
    • Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders
    • Garg A., et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch. Dermatol. 137 (2001) 53-59
    • (2001) Arch. Dermatol. , vol.137 , pp. 53-59
    • Garg, A.1
  • 32
    • 42149159403 scopus 로고    scopus 로고
    • IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo
    • [Epub 2007 Oct 25]
    • Kurahashi R., Hatano Y., and Katagiri K. IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J Invest Dermatol 128 5 (2008) 1329-1331 [Epub 2007 Oct 25]
    • (2008) J Invest Dermatol , vol.128 , Issue.5 , pp. 1329-1331
    • Kurahashi, R.1    Hatano, Y.2    Katagiri, K.3
  • 33
    • 16844386596 scopus 로고    scopus 로고
    • Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis
    • Hatano Y., et al. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J. Invest. Dermatol. 124 (2005) 786-792
    • (2005) J. Invest. Dermatol. , vol.124 , pp. 786-792
    • Hatano, Y.1
  • 34
    • 34250828434 scopus 로고    scopus 로고
    • Cytokine modulation of atopic dermatitis filaggrin skin expression
    • Howell M.D., et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 120 (2007) 150-155
    • (2007) J. Allergy Clin. Immunol. , vol.120 , pp. 150-155
    • Howell, M.D.1
  • 35
    • 9644270181 scopus 로고    scopus 로고
    • Reciprocal regulation of permeability through a cultured keratinocyte sheet by IFN-gamma and IL-4
    • Kobayashi J., et al. Reciprocal regulation of permeability through a cultured keratinocyte sheet by IFN-gamma and IL-4. Cytokine 28 (2004) 186-189
    • (2004) Cytokine , vol.28 , pp. 186-189
    • Kobayashi, J.1
  • 36
    • 0142088933 scopus 로고    scopus 로고
    • Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse
    • Cork M.J., et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br. J. Dermatol. 149 (2003) 582-589
    • (2003) Br. J. Dermatol. , vol.149 , pp. 582-589
    • Cork, M.J.1
  • 37
    • 0028593915 scopus 로고
    • Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption
    • Wood L.C., et al. Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J. Invest. Dermatol. 103 (1994) 834-838
    • (1994) J. Invest. Dermatol. , vol.103 , pp. 834-838
    • Wood, L.C.1
  • 38
    • 0036153739 scopus 로고    scopus 로고
    • Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models
    • Sheu M.Y., et al. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J. Invest. Dermatol. 118 (2002) 94-101
    • (2002) J. Invest. Dermatol. , vol.118 , pp. 94-101
    • Sheu, M.Y.1
  • 39
    • 42949178186 scopus 로고    scopus 로고
    • Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology
    • Schmuth M., et al. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J. Lipid Res. 49 (2008) 499-509
    • (2008) J. Lipid Res. , vol.49 , pp. 499-509
    • Schmuth, M.1
  • 40
    • 38049174496 scopus 로고    scopus 로고
    • Thematic review series: skin lipids. Antimicrobial lipids at the skin surface
    • Drake D.R., et al. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J. Lipid Res. 49 (2008) 4-11
    • (2008) J. Lipid Res. , vol.49 , pp. 4-11
    • Drake, D.R.1
  • 41
    • 67349089129 scopus 로고    scopus 로고
    • Barrier repair therapy for atopic dermatitis: Corrective lipid biochemical therapy based upon new pathogenic insights
    • in press
    • Elias, P., Barrier repair therapy for atopic dermatitis: corrective lipid biochemical therapy based upon new pathogenic insights. Future Drugs (in press)
    • Future Drugs
    • Elias, P.1
  • 42
    • 0034745637 scopus 로고    scopus 로고
    • Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment
    • Ashida Y., et al. Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J. Invest. Dermatol. 116 (2001) 261-265
    • (2001) J. Invest. Dermatol. , vol.116 , pp. 261-265
    • Ashida, Y.1
  • 43
    • 0036853074 scopus 로고    scopus 로고
    • New strategies to improve skin barrier homeostasis
    • Denda M. New strategies to improve skin barrier homeostasis. Adv. Drug Deliv. Rev. 54 Suppl. 1 (2002) S123-S130
    • (2002) Adv. Drug Deliv. Rev. , vol.54 , Issue.SUPPL. 1
    • Denda, M.1
  • 44
    • 67349238339 scopus 로고    scopus 로고
    • Histamine inhibits the recovery of cutaneous permeability barrier via its effect on IL-4 secretion followed by STAT6 activation. IID
    • In press
    • Katagiri, K. and Kurahashi, R. (2008) Histamine inhibits the recovery of cutaneous permeability barrier via its effect on IL-4 secretion followed by STAT6 activation. IID, J Inv Dermatol. In press
    • (2008) J Inv Dermatol
    • Katagiri, K.1    Kurahashi, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.